首页> 外文期刊>Journal of interventional cardiology >Editorial: contrast-induced acute kidney injury: shifting from elective to urgent coronary intervention.
【24h】

Editorial: contrast-induced acute kidney injury: shifting from elective to urgent coronary intervention.

机译:社论:对比剂诱发的急性肾损伤:从选择性治疗转向紧急冠状动脉介入治疗。

获取原文
获取原文并翻译 | 示例
       

摘要

Contrast-induced acute kidney injury (CI-AKI) remains an important and potentially avoidable complication after coronary angiography and intervention.1 There is a direct inverse relationship between the estimated glomerular filtration rate (eGFR) and the risk of CI-AKI. In the setting of severely reduced renal filtration, there is greater risk for more sustained intra-renal vasoconstriction, tubular and peritubular stasis of contrast, cellular toxicity, and permanent loss of some functioning nephrons (Fig. I). There is recent appreciation that iodinated contrast stays within the kidney and probably in the peritubular space for a week or more after contrast administration, causing clinical trialists to consider extending postprocedure antioxidants from the traditional 2 up to 8 days. During this prolonged contrast exposure, it is believed that the direct cellular toxicity of iodinated contrast sets up a wavefront of oxidative injury as adjacent renal tubular cells undergo injury and death. Each cell liberates tiny amounts of labile iron from organelles into the interstitial and urinary spaces. Labile iron allows the transfer of oxygen and hydrogen by critical reactions that lead to the generation of peroxides and other reactive oxygen species that then go on to injure adjacent cells.
机译:造影剂引起的急性肾损伤(CI-AKI)仍然是冠状动脉造影和干预后的重要且可能避免的并发症。1估计的肾小球滤过率(eGFR)与CI-AKI的风险之间存在直接的反比关系。在严重减少肾脏滤过的情况下,存在更大的风险,使肾脏持续进行血管内收缩,造影剂的肾小管和肾小管淤滞,细胞毒性以及某些功能性肾单位永久性丢失(图I)。最近有人意识到,碘化造影剂在造影剂给药后的一个星期内或更长时间内会留在肾脏中,并可能在肾小管周间隙中停留,这导致临床试验人员考虑将手术后的抗氧化剂从传统的2天延长至8天。在这种延长的造影剂暴露期间,据信碘化造影剂的直接细胞毒性在相邻肾小管细胞遭受损伤和死亡时建立了氧化损伤的波前。每个细胞从细胞器中释放出少量的不稳定铁进入间质和尿液空间。不稳定的铁允许通过关键反应转移氧气和氢气,导致生成过氧化物和其他活性氧,然后继续伤害邻近的细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号